微塑料
医学
泌尿生殖系统
前列腺癌
药品
癌症
药理学
药物输送
靶向给药
纳米载体
生物信息学
内分泌系统
前列腺
药代动力学
人类健康
肿瘤科
内科学
公共卫生
癌症研究
重症监护医学
药物开发
2019年冠状病毒病(COVID-19)
食品药品监督管理局
环境卫生
杀菌剂
恩扎鲁胺
诺如病毒
风险评估
生物技术
膀胱癌
机制(生物学)
作者
Kannan Sridharan,Brigida Anna Maiorano,Farah Rehan,Francesca Maradonna,Elisabetta Giorgini,Tarek Taha,Javier Molina‐Cerrillo,Sebastiano Buti,Francesco Piva,Francesco Massari,Matteo Santoni
标识
DOI:10.1038/s43856-026-01675-7
摘要
Microplastics and nanoplastics (MNPs) are environmental contaminants increasingly detected in human tissues, raising public health concerns. Although evidence is still insufficient to directly link MNPs to genitourinary cancers (GU), this Review examines their potential role in prostate, bladder, and renal cell carcinoma. Proposed mechanisms include chronic inflammation, oxidative stress, genotoxicity, and endocrine disruption driven by plastic-associated additives. Emerging studies report quantitative detection of MNPs within human prostate and bladder tumors, with higher burdens associated with dietary habits such as frequent take-out food consumption. The Review also highlights their role in cancer therapy: MNPs may alter antineoplastic drug pharmacokinetics and promote resistance, yet polymer-based nanoparticles can be engineered as advanced drug delivery platforms. Materials such as PLGA and PEG may improve targeted delivery of chemotherapies and immunotherapies, supporting more effective and personalized treatment strategies in GU oncology.
科研通智能强力驱动
Strongly Powered by AbleSci AI